HEADER PROTEIN TRANSPORT/EXCHANGE FACTOR 28-OCT-03 1R8R OBSLTE 10-FEB-04 1R8R 1S9D TITLE ARF1[DELTA 1-17]-GDP-MG IN COMPLEX WITH BREFELDIN A AND A TITLE 2 SEC7 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYLATION FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 18-181; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ARNO; COMPND 8 CHAIN: E; COMPND 9 FRAGMENT: SEC7 DOMAIN (RESIDUES 50-252); COMPND 10 SYNONYM: ARF NUCLEOTIDE-BINDING SITE OPENER, CYTOHESIN 2, COMPND 11 ARF EXCHANGE FACTOR; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 GENE: ARF1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 GENE: PSCD2, ARNO; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET11D KEYWDS PROTEIN TRANSPORT/EXCHANGE FACTOR EXPDTA X-RAY DIFFRACTION AUTHOR L.RENAULT,B.GUIBERT,J.CHERFILS REVDAT 2 10-FEB-04 1R8R 1 OBSLTE REVDAT 1 20-JAN-04 1R8R 0 JRNL AUTH L.RENAULT,B.GUIBERT,J.CHERFILS JRNL TITL STRUCTURAL SNAPSHOTS OF THE MECHANISM AND JRNL TITL 2 INHIBITION OF A GUANINE NUCLEOTIDE EXCHANGE FACTOR JRNL REF NATURE V. 426 525 2003 JRNL REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 41588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2225 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3171 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 181 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 ALL ATOMS : 3170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.96000 REMARK 3 B22 (A**2) : -1.96000 REMARK 3 B33 (A**2) : 3.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.114 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.808 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2937 ; 0.026 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2646 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3964 ; 1.945 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6146 ; 1.008 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 345 ; 5.846 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 432 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3214 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 600 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 636 ; 0.230 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3210 ; 0.263 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1653 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 226 ; 0.177 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.002 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.241 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 57 ; 0.284 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.144 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1728 ; 1.239 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2781 ; 2.099 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1209 ; 3.297 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1183 ; 5.138 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 0 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 18 A 178 REMARK 3 RESIDUE RANGE : 401 402 REMARK 3 ORIGIN FOR THE GROUP (A): 39.7581 16.4036 32.9009 REMARK 3 T TENSOR REMARK 3 T11: 0.1205 T22: 0.0999 REMARK 3 T33: 0.1331 T12: 0.0017 REMARK 3 T13: 0.0006 T23: 0.0193 REMARK 3 L TENSOR REMARK 3 L11: 2.4660 L22: 1.1175 REMARK 3 L33: 0.9834 L12: 0.2955 REMARK 3 L13: 0.0856 L23: -0.3094 REMARK 3 S TENSOR REMARK 3 S11: -0.1089 S12: 0.0857 S13: 0.1865 REMARK 3 S21: 0.0551 S22: -0.0822 S23: -0.1570 REMARK 3 S31: -0.0539 S32: 0.0447 S33: 0.1912 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 57 E 249 REMARK 3 ORIGIN FOR THE GROUP (A): 22.9252 -5.5566 23.5297 REMARK 3 T TENSOR REMARK 3 T11: 0.1815 T22: 0.1802 REMARK 3 T33: 0.0961 T12: -0.0165 REMARK 3 T13: 0.0115 T23: -0.0744 REMARK 3 L TENSOR REMARK 3 L11: 0.9328 L22: 2.2651 REMARK 3 L33: 1.1294 L12: -0.3000 REMARK 3 L13: 0.1423 L23: 0.4778 REMARK 3 S TENSOR REMARK 3 S11: 0.0756 S12: 0.1889 S13: -0.1803 REMARK 3 S21: -0.1340 S22: 0.0325 S23: -0.0772 REMARK 3 S31: 0.2090 S32: 0.0827 S33: -0.1081 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 1R8R COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-NOV-2003. REMARK 100 THE RCSB ID CODE IS RCSB020577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43814 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 12.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 FOR THE DATA SET : 26.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 12.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40500 REMARK 200 FOR SHELL : 6.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: CRYSTAL STRUCTURE OF THE ARF1[D1-17]/GEA2-SEC7 REMARK 200 COMPLEX (GOLDBERG, J., (1998) CELL 95(2):237-48) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 29% PEG 3350, 40MM NH4CL, 40MM REMARK 280 POTASSIUM FORMATE, 100MM TRIS, PH 8, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,1/2+Z REMARK 290 3555 1/2-Y,1/2+X,1/4+Z REMARK 290 4555 1/2+Y,1/2-X,3/4+Z REMARK 290 5555 1/2-X,1/2+Y,1/4-Z REMARK 290 6555 1/2+X,1/2-Y,3/4-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,1/2-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.26700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.73100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.73100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.63350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.73100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.73100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.90050 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.73100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.73100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.63350 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.73100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.73100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.90050 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.26700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH 284 LIES ON A SPECIAL POSITION. REMARK 375 HOH 286 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 39 REMARK 465 GLY A 40 REMARK 465 GLU A 41 REMARK 465 ILE A 42 REMARK 465 VAL A 43 REMARK 465 THR A 44 REMARK 465 ASN A 179 REMARK 465 GLN A 180 REMARK 465 LYS A 181 REMARK 465 LEU E 50 REMARK 465 GLU E 51 REMARK 465 ALA E 52 REMARK 465 ASN E 53 REMARK 465 GLU E 54 REMARK 465 GLY E 55 REMARK 465 SER E 56 REMARK 465 GLY E 250 REMARK 465 ASN E 251 REMARK 465 ASP E 252 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 NZ LYS A 38 O HOH 2 1.95 REMARK 500 OD1 ASN A 101 O HOH 63 2.11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 22 SD MET A 22 CE -0.467 REMARK 500 MET A 110 SD MET A 110 CE -0.166 REMARK 500 MET E 216 SD MET E 216 CE -0.339 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R8M RELATED DB: PDB REMARK 900 THE SAME MUTATED SEC7 DOMAIN OF ARNO SOLVED ISOLATED REMARK 900 RELATED ID: 1PBV RELATED DB: PDB REMARK 900 THE WILD TYPE CONSTRUCT OF THE SEC7 DOMAIN OF ARNO SOLVED REMARK 900 ISOLATED REMARK 900 RELATED ID: 1R8Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ABORTIVE ARF1/GDP/MG/BREFELDIN A/ REMARK 900 ARNO-SEC7[F190Y/A191S/S198D/P208M] COMPLEX REMARK 900 RELATED ID: 1R8S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ABORTIVE ARF1[D1-17]/GDP/ARNO- REMARK 900 SEC7[F190Y/A191S/S198D/P208M/E156K] COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE ENGINEERED MUTATIONS IN THE ARNO STRUCTURE REMARK 999 (F190Y, A191S, S198D, P208M) ARE BREFELDIN A- REMARK 999 SENSITIZING MUTATIONS. DBREF 1R8R A 18 181 UNP P32889 ARF1_HUMAN 17 180 DBREF 1R8R E 50 252 UNP Q99418 CYH2_HUMAN 50 252 SEQADV 1R8R CME E 174 UNP Q99418 CYS 174 MODIFIED RESIDUE SEQADV 1R8R TYR E 190 UNP Q99418 PHE 190 ENGINEERED SEQADV 1R8R SER E 191 UNP Q99418 ALA 191 ENGINEERED SEQADV 1R8R ASP E 198 UNP Q99418 SER 198 ENGINEERED SEQADV 1R8R MET E 208 UNP Q99418 PRO 208 ENGINEERED SEQRES 1 A 164 MET ARG ILE LEU MET VAL GLY LEU ASP ALA ALA GLY LYS SEQRES 2 A 164 THR THR ILE LEU TYR LYS LEU LYS LEU GLY GLU ILE VAL SEQRES 3 A 164 THR THR ILE PRO THR ILE GLY PHE ASN VAL GLU THR VAL SEQRES 4 A 164 GLU TYR LYS ASN ILE SER PHE THR VAL TRP ASP VAL GLY SEQRES 5 A 164 GLY GLN ASP LYS ILE ARG PRO LEU TRP ARG HIS TYR PHE SEQRES 6 A 164 GLN ASN THR GLN GLY LEU ILE PHE VAL VAL ASP SER ASN SEQRES 7 A 164 ASP ARG GLU ARG VAL ASN GLU ALA ARG GLU GLU LEU MET SEQRES 8 A 164 ARG MET LEU ALA GLU ASP GLU LEU ARG ASP ALA VAL LEU SEQRES 9 A 164 LEU VAL PHE ALA ASN LYS GLN ASP LEU PRO ASN ALA MET SEQRES 10 A 164 ASN ALA ALA GLU ILE THR ASP LYS LEU GLY LEU HIS SER SEQRES 11 A 164 LEU ARG HIS ARG ASN TRP TYR ILE GLN ALA THR CYS ALA SEQRES 12 A 164 THR SER GLY ASP GLY LEU TYR GLU GLY LEU ASP TRP LEU SEQRES 13 A 164 SER ASN GLN LEU ARG ASN GLN LYS SEQRES 1 E 203 LEU GLU ALA ASN GLU GLY SER LYS THR LEU GLN ARG ASN SEQRES 2 E 203 ARG LYS MET ALA MET GLY ARG LYS LYS PHE ASN MET ASP SEQRES 3 E 203 PRO LYS LYS GLY ILE GLN PHE LEU VAL GLU ASN GLU LEU SEQRES 4 E 203 LEU GLN ASN THR PRO GLU GLU ILE ALA ARG PHE LEU TYR SEQRES 5 E 203 LYS GLY GLU GLY LEU ASN LYS THR ALA ILE GLY ASP TYR SEQRES 6 E 203 LEU GLY GLU ARG GLU GLU LEU ASN LEU ALA VAL LEU HIS SEQRES 7 E 203 ALA PHE VAL ASP LEU HIS GLU PHE THR ASP LEU ASN LEU SEQRES 8 E 203 VAL GLN ALA LEU ARG GLN PHE LEU TRP SER PHE ARG LEU SEQRES 9 E 203 PRO GLY GLU ALA GLN LYS ILE ASP ARG MET MET GLU ALA SEQRES 10 E 203 PHE ALA GLN ARG TYR CYS LEU CME ASN PRO GLY VAL PHE SEQRES 11 E 203 GLN SER THR ASP THR CYS TYR VAL LEU SER TYR SER VAL SEQRES 12 E 203 ILE MET LEU ASN THR ASP LEU HIS ASN PRO ASN VAL ARG SEQRES 13 E 203 ASP LYS MET GLY LEU GLU ARG PHE VAL ALA MET ASN ARG SEQRES 14 E 203 GLY ILE ASN GLU GLY GLY ASP LEU PRO GLU GLU LEU LEU SEQRES 15 E 203 ARG ASN LEU TYR ASP SER ILE ARG ASN GLU PRO PHE LYS SEQRES 16 E 203 ILE PRO GLU ASP ASP GLY ASN ASP MODRES 1R8R CME E 174 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME E 174 10 HET MG 402 1 HET GDP 401 28 HET AFB 403 16 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM MG MAGNESIUM ION HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM AFB 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6- HETNAM 2 AFB METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE HETSYN AFB BREFELDIN A FORMUL 2 CME C5 H11 N O3 S2 FORMUL 3 MG MG 2+ FORMUL 4 GDP C10 H15 N5 O11 P2 FORMUL 5 AFB C16 H24 O4 FORMUL 6 HOH *286(H2 O1) HELIX 1 1 GLY A 29 LYS A 38 1 10 HELIX 2 2 GLN A 71 GLN A 83 5 13 HELIX 3 3 ASP A 96 GLU A 98 5 3 HELIX 4 4 ARG A 99 ALA A 112 1 14 HELIX 5 5 GLU A 113 ARG A 117 5 5 HELIX 6 6 ASN A 135 LEU A 143 1 9 HELIX 7 7 GLY A 144 LEU A 148 5 5 HELIX 8 8 GLY A 165 ARG A 178 1 14 HELIX 9 9 LYS E 57 ASP E 75 1 19 HELIX 10 10 ASP E 75 ASN E 86 1 12 HELIX 11 11 THR E 92 TYR E 101 1 10 HELIX 12 12 ASN E 107 GLY E 116 1 10 HELIX 13 13 GLU E 119 ASP E 131 1 13 HELIX 14 14 ASN E 139 LEU E 148 1 10 HELIX 15 15 GLU E 156 ASN E 175 1 20 HELIX 16 16 SER E 181 ASN E 201 1 21 HELIX 17 17 GLY E 209 ASN E 217 1 9 HELIX 18 18 PRO E 227 GLU E 241 1 15 SHEET 1 A 6 THR A 55 TYR A 58 0 SHEET 2 A 6 ILE A 61 VAL A 65 -1 O PHE A 63 N VAL A 56 SHEET 3 A 6 ILE A 20 VAL A 23 1 N MET A 22 O THR A 64 SHEET 4 A 6 GLY A 87 ASP A 93 1 O ILE A 89 N LEU A 21 SHEET 5 A 6 VAL A 120 ASN A 126 1 O VAL A 120 N LEU A 88 SHEET 6 A 6 TRP A 153 ALA A 157 1 O TYR A 154 N VAL A 123 CRYST1 111.462 111.462 74.534 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008972 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008972 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013417 0.00000